GEN-009
Various cancers
Phase 1/2
06/04/2021
Phase 1/2 long-term follow-up clinical and immunogenicity data to be presented at ASCO June 4, 2021.
woooh!
New data on their cancer vaccine trials to be presented at ASCO June 4-8!
financialSnail88674
⋅
@samknutsson0327, it's been trading in the channel for almost 2 years now.
and this data may lead to a breakout—whether we will see new highs or new lows.
anyway, it may be a good level (and timing) to buy more with a tight stop-loss.
Various cancers
Phase 1/2
06/04/2021
Phase 1/2 long-term follow-up clinical and immunogenicity data to be presented at ASCO June 4, 2021.
woooh!
New data on their cancer vaccine trials to be presented at ASCO June 4-8!